Healthcare worker experiences with Option B+ for prevention of mother-to-child HIV transmission in eSwatini: findings from a two-year follow-up study

Coutsoudis A(2013)Is option B+ the best choice? Lancet 381 269-271

Goga A(2014)“What they wanted was to give birth; nothing Else”: barriers to retention in option B+ HIV care among postpartum women in South Africa JAIDS. 67 e12-e18

Desmond C(2014)Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women (‘option B+’) in Malawi AIDS. 28 589-598

Clouse K(2014)Understanding factors, outcomes and reasons for loss to follow-up among women in option B+ PMTCT programme in Lilongwe Malawi Trop Med Int Heal 19 1360-1366

Schwartz S(2015)Implementation and operational research: the impact of option B+ on the antenatal PMTCT cascade in Lilongwe Malawi J Acuir Immune Defic Syndr 68 e77-e83

Van Rie A(2015)Initial programmatic implementation of WHO option B in Botswana associated with increased projected MTCT JAIDS. 68 245-249

Tenthani L(2014)Lessons learned from early implementation of option B+: the Elizabeth Glaser Pediatric AIDS Foundation experience in 11 African countries J Acquir Immune Defic Syndr 67 S188-S194

Haas AD(1999)Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda. HIVNET 012 randomised trial Lancet 354 795-802

Tweya H(2013)How option B+ is shifting the PMTCT paradigm African J Midwifery Women’s Heal 7 7-13

Tweya L(2016)A comprehensive review of the barriers and promoters health workers experience in delivering prevention of vertical transmission of HIV services in sub-Saharan Africa AIDS Care 121 1-17

Coutsoudis A(2013)Is option B+ the best choice? Lancet 381 269-271

Goga A(2014)“What they wanted was to give birth; nothing Else”: barriers to retention in option B+ HIV care among postpartum women in South Africa JAIDS. 67 e12-e18

Desmond C(2014)Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women (‘option B+’) in Malawi AIDS. 28 589-598

Clouse K(2014)Understanding factors, outcomes and reasons for loss to follow-up among women in option B+ PMTCT programme in Lilongwe Malawi Trop Med Int Heal 19 1360-1366

Schwartz S(2015)Implementation and operational research: the impact of option B+ on the antenatal PMTCT cascade in Lilongwe Malawi J Acuir Immune Defic Syndr 68 e77-e83

Van Rie A(2015)Initial programmatic implementation of WHO option B in Botswana associated with increased projected MTCT JAIDS. 68 245-249

Tenthani L(2014)Lessons learned from early implementation of option B+: the Elizabeth Glaser Pediatric AIDS Foundation experience in 11 African countries J Acquir Immune Defic Syndr 67 S188-S194

Haas AD(1999)Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda. HIVNET 012 randomised trial Lancet 354 795-802

Tweya H(2013)How option B+ is shifting the PMTCT paradigm African J Midwifery Women’s Heal 7 7-13

Tweya L(2016)A comprehensive review of the barriers and promoters health workers experience in delivering prevention of vertical transmission of HIV services in sub-Saharan Africa AIDS Care 121 1-17